Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
February 3, 2005
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis
Tobias Larsson, Xijie Yu, Siobhan I Davis, et al.
JBMR Plus
|
November 11, 2025
Multi-tissue spatial transcriptomics identified simultaneous responses to oxidative stress and apoptosis in parallel with tissue-specific reprogramming in modeled chronic kidney disease-mineral and bone disorder
Lainey M Hibbard, Sheng Liu, Yamil G Marambio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2008
Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia
Whitney W Brown, Harald Jüppner, Craig B Langman, et al.
Endocrinology
|
November 21, 2015
Gene-by-Diet Interactions Affect Serum 1,25-Dihydroxyvitamin D Levels in Male BXD Recombinant Inbred Mice
James C Fleet, Rebecca A Replogle, Perla Reyes-Fernandez, et al.
Endocrinology
|
June 18, 2005
Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed
Tobias Larsson, Siobhan I Davis, Holly J Garringer, et al.
American Journal of Medical Genetics. Part A
|
September 14, 2007
Two novel GALNT3 mutations in familial tumoral calcinosis
Holly J Garringer, Seyed Mohammad Javad Mortazavi, Fatemehsadat Esteghamat, et al.
American Journal of Medical Genetics. Part A
|
February 14, 2006
Extended mutational analyses of FGFR1 in osteoglophonic dysplasia
Emily G Farrow, Siobhan I Davis, Sean D Mooney, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 10, 2011
The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat
Sharon M Moe, J Scott Radcliffe, Kenneth E White, et al.
Physiological Reports
|
June 2, 2020
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Megan L Noonan, Erica L Clinkenbeard, Pu Ni, et al.
Endocrinology
|
July 23, 2014
Genetic rescue of glycosylation-deficient Fgf23 in the Galnt3 knockout mouse
Shoji Ichikawa, Amie K Gray, Leah R Padgett, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Endocrinology and Metabolism
|
February 3, 2005
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis
Tobias Larsson, Xijie Yu, Siobhan I Davis, et al.
JBMR Plus
|
November 11, 2025
Multi-tissue spatial transcriptomics identified simultaneous responses to oxidative stress and apoptosis in parallel with tissue-specific reprogramming in modeled chronic kidney disease-mineral and bone disorder
Lainey M Hibbard, Sheng Liu, Yamil G Marambio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2008
Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia
Whitney W Brown, Harald Jüppner, Craig B Langman, et al.
Endocrinology
|
November 21, 2015
Gene-by-Diet Interactions Affect Serum 1,25-Dihydroxyvitamin D Levels in Male BXD Recombinant Inbred Mice
James C Fleet, Rebecca A Replogle, Perla Reyes-Fernandez, et al.
Endocrinology
|
June 18, 2005
Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed
Tobias Larsson, Siobhan I Davis, Holly J Garringer, et al.
American Journal of Medical Genetics. Part A
|
September 14, 2007
Two novel GALNT3 mutations in familial tumoral calcinosis
Holly J Garringer, Seyed Mohammad Javad Mortazavi, Fatemehsadat Esteghamat, et al.
American Journal of Medical Genetics. Part A
|
February 14, 2006
Extended mutational analyses of FGFR1 in osteoglophonic dysplasia
Emily G Farrow, Siobhan I Davis, Sean D Mooney, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 10, 2011
The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat
Sharon M Moe, J Scott Radcliffe, Kenneth E White, et al.
Physiological Reports
|
June 2, 2020
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Megan L Noonan, Erica L Clinkenbeard, Pu Ni, et al.
Endocrinology
|
July 23, 2014
Genetic rescue of glycosylation-deficient Fgf23 in the Galnt3 knockout mouse
Shoji Ichikawa, Amie K Gray, Leah R Padgett, et al.
Page
of 9